Nature's Toolbox
Private Company
Total funding raised: $6.5M
Overview
NTx Bio is a private, platform technology company founded in 2016, headquartered in Rio Rancho, New Mexico, USA. The company has developed proprietary, automated bioreactor systems and enzymes for cell-free synthesis, aiming to make RNA and protein manufacturing faster, cheaper, and more accessible than traditional batch-based, outsourced methods. Its technology promises linear scalability and push-button operation, targeting researchers and therapeutic developers who need agile production for next-generation modalities like mRNA vaccines and cell therapies. NTx Bio appears to be in an early commercial stage, generating revenue by selling its manufacturing systems and consumables to enable its partners' pipelines.
Technology Platform
Proprietary automated, continuous-flow, cell-free biomanufacturing platforms (NTxscribe for RNA, NTxpress for protein) utilizing custom enzymes for efficient, scalable, on-demand production.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
NTx Bio competes with traditional CDMOs using batch IVT and with other startups developing alternative mRNA production technologies (e.g., continuous flow, enzymatic synthesis). Its differentiation lies in its integrated system of proprietary hardware, enzymes, and push-button automation designed for in-house, benchtop use.